Medicine - Xagena

Medicine

News

Drugs

Xapedia

Farmaci

Farmacia

Medicina

Specialità

Progressive multifocal leukoencephalopathy in CellCept treated patients

Provigil associated with serious rash and psychiatric symptoms

Ductal carcinoma in situ: patients overestimate breast cancer risks

HPV-positive head and neck cancer patients have a better response and survival than HPV-negative patients

Additional changes to Ortho Evra, a birth control patch

Six infection-related deaths reported after treatment with MabCampath in patients with B-cell chronic lymphocytic leukemia

Tysabri to treat moderate-to-severe Crohn's disease: FDA has approved

Alpha-Linolenic acid in treatment for dry eye syndrome

Oxcarbazepine does not appear to prevent migraine

Additional trials have shown increased mortality and/or tumor progression with Epogen / Procrit and Aranesp

COPD: is Spiriva associated with increased risk of stroke ?

Reversal of hypoglycemia in animal model of glycogen storage disease type Ia

Neuropsychiatric events associated with Tamiflu

Lupus: blocked signals to immune cells extend their life and contribute to progression of disease

Crohn's disease: combined immunosuppression therapy better than conventional treatment

Avastin: VEGF neutralization can damage brain vessels

Immunosuppressants: Mycophenolate mofetil linked to specific birth defect pattern

Potential biomarkers for psychosis and cerebrovascular disease in patients with systemic lupus erythematosus

Biochemical bases of 1918 flu pandemic

Genetic variation to predict initial response to Warfarin identified

Endeavor, a drug-eluting stent for treatment of narrowed coronary arteries

WHI follow up study: risks of long-term combination hormone therapy outweigh benefits for postmenopausal women

Oral Terbinafine can be associated with rare but serious and life-threatening toxicities

Tysabri may cause liver injury

Arcalyst is first treatment for cryopyrin-associated periodic syndromes

Gastroesophageal reflux disease: FDA has approved Nexium for use in children ages 1-11 years

Relapsing-remitting multiple sclerosis: Rituximab shows promise

Rheumatoid arthritis: cardiovascular benefits of anti-TNF therapy

Acute coronary syndrome: patients at risk of adverse events within 3 months after stopping Clopidogrel treatment

Anemic cancer patients: erythropoiesis-stimulating agents increase risk of death

Oral Buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease

Risk of suicidal thoughts and behavior with antiepileptic drugs

Two deaths after HPV vaccine Gardasil

Importance of pneumococcal vaccination in cochlear implant recipients

Cervarix, a HPV vaccine, is not therapeutic in women with preexisting infection

Replagal for the treatment of Fabry disease

Golimumab improves psoriatic arthritis symptoms

DIM, a compound in broccoli, could boost immune system

Blocking angiogenesis signaling from inside cell may lead to serious health problems

Hypersensitivity reactions to Pregabalin

Varenicline: possible effects on driving and psychiatric illness

Zolpidem: adverse neurological and psychiatric reactions

Tesamorelin reduces abdominal fat accumulation and improves lipids in HIV-infected patients

Possible role of prolactin in breast cancer

Acute coronary syndrome therapy improvements linked with fewer deaths and improved clinical outcomes

Antidepressants: daily use of SSRIs associated with increased risk of fracture in older adults

Postmenopausal women: Calcium plus vitamin D supplements may help prevent weight gain

Waist-to-hip ratio may better predict cardiovascular risk than body mass index

Maternal obesity prior to pregnancy associated with birth defects

ADHD appears to be associated with depressed dopamine activity in the brain

Fluctuating eye pressure associated with visual field deterioration in glaucoma patients

Irinotecan plus Bevacizumab in the treatment of glioblastoma multiforme

NSAIDs and coxibs: balancing of cardiovascular and gastrointestinal risk

Short-acting beta-agonists associated with myocardial ischaemia

FDA: new warning for Nonoxynol 9 OTC contraceptive products

Ace inhibitors and sartans: not for use in pregnancy

Computed tomography screening may increase lung cancer diagnosis, but not decrease risk of death

Decompensated heart failure: Levosimendan does not improve survival, compared to Dobutamine

Rosiglitazone and Pioglitazone: cardiovascular safety

FDA has approved Kuvan for treatment of phenylketonuria

FDA: second safety warning on Duragesic

Recombinant human erythropoietins: new prescribing advice

Finasteride unlikely to induce high-grade prostate tumor

Supracervical hysterectomy not superior to total hysterectomy

Routine thyroid screening not recommended for pregnant women

Glioblastoma multiforme: Bevacizumab shows encouraging results in phase II study

Reports of deaths and serious cardiopulmonary reactions following the administration of ultrasound micro-bubble contrast agents

FDA has approved Bystolic, a beta-blocker, to treat hypertension

Acute coronary syndromes: treating depression may reduce cardiac risk

Invasive breast cancer: biomarkers predict risk years before the tumor develops

The WHI Dietary Modification Trial: low fat diet may lower risk of ovarian cancer

Long-term pharmacotherapy for obesity and overweight: modest weight loss

Serotonin receptor agonists, a faster class of antidepressants

Zolpidem and bizarre sleep related effects

Citalopram, an antidepressant, has shown early promise in treating agitation and psychotic symptoms of dementia

Genes linked to suicidal thinking during antidepressant treatment

HIJ-CREATE trial: Candesartan reduces the incidence of MACE in patients with impaired renal function in addition to reduction of new onset of diabetes mellitus

Increased mortality among patients treated with Cefepime

Transient increase in cervical cancer risk in oral contraceptive users

Voltaren Gel for treatment of pain associated with osteoarthritis

Type 2 diabetes: FDA has added boxed warning for heart-related Risks to Avandia

FDA has approved Nexavar for patients with inoperable hepatocellular carcinoma

FDA: Crestor approved to slow the progression of atherosclerosis in patients with elevated cholesterol

Chronic myeloid leukaemia: Imatinib proves safe and effective over the long term

Hepatitis C: Peginterferon alfa-2a reduces the virus but serious liver problems may progress

Selective serotonin reuptake inhibitors can double risk of gastrointestinal bleeding

Rimonabant is associated with severe adverse psychiatric events

Pioglitazone and Rosiglitazone may reduce bone density

Renal impairment associated with Zoledronic acid

Erythropoiesis-stimulating agents: FDA has strengthened boxed warnings and has approved other safety labeling changes

STEP study: an investigational HIV vaccine is not effective

Drug-induced pancreatitis

TNF-alpha inhibitors are associated with several serious reactions

Novartis has proposed improving Galvus risk/benefit profile through use of approved 50 mg once-daily and twice-daily doses instead of approved 100 mg once-daily

The endocannabinoid system

FDA has requested marketing suspension of Trasylol, an antifibrinolytic drug

Chronic hepatitis B: Viread more effective than Hepsera

Pegasys provides hepatitis C patients a second chance to achieve a cure after not responding to Peg-Intron

Higher intake of fish and Vitamin-D levels linked to lower risk of age-related macular disease

Chemotherapy with Avastin increases risk of arterial thromboembolic events

Pagine successive 1 [2] 3 4 5 6 7 8 9 10 »

Link

Specialità

Patologie

Patologie

© XAGENA 2010 - P.IVA: 04454930969 - REA: 1748680 - Tutti i diritti riservati